Efficacy of sialic acid supplementation in early life in autism model rats
Authors:
Open Access
- 12 March 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Abstract
Autism spectrum disorder (ASD) is a set of heterogeneous neurodevelopmental conditions, the etiology of which remains elusive. Sialic acid (SA) is an essential nutrient for nervous system development, and previous studies reported that the levels of SA were decreased in the blood and saliva of ASD children. However, it is not clear whether SA supplementation can alleviate behavioral problems in autism. We administered SA intervention in the VPA-induced autism model rats, evaluated behavior performance, and measured the levels of Gne and St8sia2 genes, BDNF and anti-GM1. At the same time, untargeted metabolomics was used to characterize the metabolites. It was found that the stereotypical behaviors, social preference and cognitive function were improved after SA supplementation. Additionally, the number of hippocampal neurons was increased, and the shape was normalized. Moreover, 94 differentially abundant metabolites were identified between the high dose SA and VPA groups. These changes in metabolites were correlated with pyrimidine metabolism, lysine degradation metabolism, biosynthesis of amino acids, mineral absorption, protein digestion and absorption, galactose metabolism, phenylalanine, tyrosine and tryptophan biosynthesis and phenylalanine metabolism. In conclusion, SA could ameliorate ASD-like phenotypes and change metabolites in autistic animals, which suggests that it may be a therapeutic approach for ASD.Keywords
Funding Information
- National Natural Science Foundation of China (No. 82103869)
- Postdoctoral Research Foundation of Heilongjiang (No. LBH-QY22004)
This publication has 49 references indexed in Scilit:
- Urinary neopterin and biopterin indicate that inflammation has a role in autism spectrum disorderMetabolic Brain Disease, 2023
- Imputing cognitive impairment in SPARK, a large autism cohortAutism Research, 2021
- Untargeted Metabolomics Screen of Mid‐pregnancy Maternal Serum and Autism in OffspringAutism Research, 2020
- Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors2020
- The association between NCAM1 levels and behavioral phenotypes in children with autism spectrum disorderBehavioural Brain Research, 2019
- Mental disorders and an acidic glycan-from the perspective of polysialic acid (PSA/polySia) and the synthesizing enzyme, ST8SIA2Glycoconjugate Journal, 2018
- Releasing Mechanism of Neurotrophic Factors via Polysialic Acid2017
- Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literatureAmino Acids, 2016
- Characterization of a 520 kb deletion on chromosome 15q26.1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsyAmerican Journal of Medical Genetics Part A, 2013
- Anti-GM1 antibodies as a model of the immune response to self-glycansBiochimica et Biophysica Acta (BBA) - General Subjects, 2007